Taysha Gene Therapies
TSHA
TSHA
125 hedge funds and large institutions have $232M invested in Taysha Gene Therapies in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 129 → 125 (-4)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
20% less capital invested
Capital invested by funds: $290M → $232M (-$57.7M)
Holders
125
Holding in Top 10
2
Calls
$144K
Puts
$7K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$6.35M | |
| 3 | +$2.25M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.24M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$1.05M |
Top Sellers
| 1 | -$8.65M | |
| 2 | -$5.58M | |
| 3 | -$4.5M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.28M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.53M |
